Skip to main content

Table 4 The distribution of combinations of Arg399Gln of gene XRCC1 and T309G of gene MDM2 polymorphic markers in Kyrgyz women with BC and controls

From: The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females

XRCC1/MDM2 genotypes

Cases, n (%)

Controls, n (%)

OR (95% CI)

χ2

Arg399Arg/G309G

12 (10)

17 (17)

Reference

 

Arg399Arg/T309G

18 (15)

31 (30)

0.82 (0.32–2.11)

0.17/0.684

Arg399Arg/T309T

8 (7)

8 (8)

1.42 (0.42–4.84)

0.31/0.578

Arg399Gln/ G309G

14 (12)

8 (8)

2.48 (0.79–7.76)

2.48/0.115

Arg399Gln/ T309G

38 (32)

18 (18)

3.00 (1.18–7.56)

4.49/0.034

Arg399Gln/ T309T

16 (14)

8 (8)

2.83 (0.92–8.73)

3.37/0.066

Gln399Gln/ G309G

3 (3)

3 (3)

1.42 (0.24–8.26)

0.15/0.697

Gln399Gln/ T309G

6 (5)

6 (5)

1.42 (0.37–5.48)

0.26/0.613

Gln399Gln/ T309T

2 (2)

3 (3)

1.42 (0.17–11.51)

0.11/0.74

  1. OR odds ratio, CI confidence interval